Kuitunen Sini, Saksa Mari, Holmström Anna-Riia
Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, P.O. Box 56, 00014, Helsinki, Finland.
HUS Pharmacy, Helsinki University Hospital, Helsinki, Finland.
Drugs Real World Outcomes. 2025 Mar;12(1):45-61. doi: 10.1007/s40801-024-00469-4. Epub 2024 Dec 11.
Paediatric patients are prone to medication errors, but an in-depth understanding of errors involving high-alert medications remains limited.
We aimed to investigate incident reports involving high-alert medications to describe medication errors, error chains and stages of the medication management and use process where the errors occur in paediatric hospitals.
A retrospective document analysis of self-reported medication safety incidents in a paediatric university hospital in 2018-20. The incident reports involving high-alert medications were investigated using an inductive qualitative content analysis and quantified (frequencies and percentages). A systems approach to medication risk management based on the Theory of Human Error was applied.
Altogether, 560 medication errors were identified within the study sample (n = 426 incident reports). Most medication errors were associated with administration (43.1 %, n = 241/560) and prescribing (25.2 %, n = 141/560). Error chains involving two to four medication errors in one or more stages of the medication management and use process were present in 26.1% (n = 111/426) of reports, most of which originated from prescribing (62.2%; n = 69/111). The medication errors (n = 560) were classified into 14 main categories, the most common of which were wrong dose (13.9%; n = 78/560), omission of a drug (12.9%; n = 72/560) and documentation errors (10.0%; n = 56).
Paediatric medication error chains often start from prescribing and pass through the medication management and use process. Systemic defences are especially needed for manual tasks leading to wrong doses, drug omission and documentation errors. Intravenous medications and chemotherapeutic agents, optimising drug formularies and handling, and high-alert drug use at home require further actions in paediatric medication risk management.
儿科患者容易出现用药错误,但对涉及高警示药物的错误的深入了解仍然有限。
我们旨在调查涉及高警示药物的事件报告,以描述儿科医院用药错误、错误链以及错误发生的用药管理和使用过程阶段。
对一家儿科大学医院2018 - 2020年自我报告的用药安全事件进行回顾性文件分析。使用归纳定性内容分析法对涉及高警示药物的事件报告进行调查并量化(频率和百分比)。应用基于人为错误理论的用药风险管理系统方法。
在研究样本(n = 426份事件报告)中总共识别出560例用药错误。大多数用药错误与给药(43.1%,n = 241/560)和处方(25.2%,n = 141/560)有关。在26.1%(n = 111/426)的报告中,用药管理和使用过程的一个或多个阶段存在涉及两到四个用药错误的错误链,其中大部分源于处方(62.2%;n = 69/111)。用药错误(n = 560)被分为14个主要类别,最常见的是剂量错误(13.9%;n = 78/560)、漏服药物(12.9%;n = 72/560)和记录错误(10.0%;n = 56)。
儿科用药错误链通常始于处方,并贯穿用药管理和使用过程。对于导致剂量错误、漏服药物和记录错误的手工任务,尤其需要系统防御措施。静脉用药和化疗药物、优化药品处方集和处理以及在家中使用高警示药物在儿科用药风险管理中需要进一步采取行动。